What Medicare Claims Reveal About Adverse Drug Events

April 18, 2019

Resources for Payers, Patients, Caregivers, Providers, Pharmacists, and Researchers

Recognized as a largely preventable source of harm to patients, Adverse Drug Events (ADEs) are a public health issue that require ongoing surveillance. Seniors are especially vulnerable with more than 40 percent taking five or more medications to manage chronic conditions such as hypertension, diabetes, COPD, and heart failure.

Despite the known risk, there is no national system for measuring and monitoring outpatient ADE rates among seniors. A team of Telligen data analysts, working under contract with CMS, addressed this limitation by developing a method that uses Medicare claims to:

  • Identify populations at high-risk for adverse events;
  • Calculate rates of hospitalization among the high-risk population; and
  • Share the data for targeted quality interventions.

The end result is a population health monitoring source for tracking medication use patterns, health outcomes, and ADE rates for targeted quality improvement efforts.

Telligen ADE Resources:

Download the Infographic

What payers, patients, providers, and pharmacists need to know about ADEs among elderly populations

Review the Highlights

Overview of the objectives, methods, and results of Telligen’s peer-reviewed study

Read the Full Study

Published in the March 2019 issue of Journal of Managed Care & Specialty Pharmacy

Scroll Through the Story

How the study will can help Medicare enhance prevention and monitoring for quality improvement efforts

Image 01 Image 02